Viewing nowCombinationEmpagrombi Tablet 5/500 mg (Empagliflozin, Metformin hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aprogen Biosolutions Co., Ltd.

MFDS item code 202201333 · Approved 2022.04.04 · Insurance code 645210980
Improvement of glycemic control in adults with type 2 diabetes
This medication is used as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes. It is particularly suitable for adult patients being treated with a combination of empagliflozin and metformin. Caution is needed for type 2 diabetes patients with cardiovascular disease when glycemic control is insufficient to assess the risk of cardiovascular events, and relevant clinical information should also be consulted. Overall, this medication improves blood sugar management and supports patient health care.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). Elderly Patients In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication helps lower blood sugar and is used in diabetes treatment. However, it should not be used in patients with significantly impaired kidney function, acute infections, dehydration, or severe heart disease. Women who are pregnant or breastfeeding should not take this medication. During treatment, symptoms of hypoglycemia may occur, so caution is needed when using it with insulin or other hypoglycemic agents. Additionally, this medication can cause urinary or genital infections; if such symptoms occur, consult a physician immediately. It should be used cautiously in patients with poor liver or kidney function, or in situations at risk of fluid loss, and kidney function should be regularly monitored through blood tests. Temporary suspension of this medication is required before and after surgeries or tests using iodinated contrast agents, and kidney function must be confirmed before resuming treatment. This medication can lower vitamin B12 levels, so long-term users may need to check their vitamin B12 concentrations. Alcohol may increase the risk of side effects from this medication, so excessive drinking should be avoided during treatment. Furthermore, this medication can affect body fluid levels, so caution is especially necessary for the elderly or those at risk for dehydration. During the use of this medication, if symptoms such as fever, pain, swelling, or rash around the genital or perineal areas occur, healthcare providers should be informed immediately. Finally, this medication is not recommended for children under 18 years of age, and dosages for the elderly should be adjusted based on kidney function.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or humidity and must be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the drug’s efficacy.
Orange-yellow, biconvex oval film-coated tablet
10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/box [(10 tablets/PTP x 6)], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aprogen Biosolutions Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.